Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7910402 | 0.98 | ALDH1A1 (0.43) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| Hydrochloric Acid SCHEMBL7910504 | 0.98 | ALDH1A1 (0.43) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| SCHEMBL300884 | 0.86 | CA12 (0.42) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| SCHEMBL10168511 | 0.84 | ALDH1A1 (0.47) | ALDH1A1HPGDKMT2AMEN1MAPT | |
| SCHEMBL28320394 | 0.84 | ALDH1A1 (0.38) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| SCHEMBL16938405 | 0.84 | MAPT (0.54) | ALDH1A1HPGDKMT2AMEN1MAPT | |
| Hydrochloric Acid SCHEMBL28721885 | 0.83 | ALDH1A1 (0.37) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| Hydrochloric Acid SCHEMBL29064019 | 0.83 | MAPT (0.53) | ALDH1A1HPGDKMT2AMEN1MGLL | |
| SCHEMBL7327634 | 0.82 | HPGD (0.46) | ALDH1A1HPGDKMT2AMEN1MAPT | |
| SCHEMBL12216547 | 0.81 | LMNA (0.44) | ALDH1A1HPGDKMT2AMAPTCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114040760-B | Irreversible inhibitors of MENIN-MLL interactions | 拜欧米富士恩公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119841834-A | Irreversible inhibitors of MENIN-MLL interactions | 拜欧米富士恩公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20250020674-A1 | CHOLESTEROL-RICH LIPOPROTEIN NANOPARTICLES FOR CANCER DIAGNOSIS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2025-01-16 | — | — | US | disclosed |
| CN-113195471-B | Polysubstituted pyridone derivative and application thereof in medicine | 苏州浦合医药科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-10414826-B2 | Monomethylvaline compounds capable of conjugation to ligands | SEATTLE GENETICS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| US-20180127512-A1 | MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS | SEAGEN INC. | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127512-A1 | MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS | MMAB, CAD, VIM | ALDH1A1 3456/4885HPGD 2535/4885KMT2A 2858/4885 |
| US-10414826-B2 | Monomethylvaline compounds capable of conjugation to ligands | MMAB, CAD, VIM | ALDH1A1 3456/4885HPGD 2535/4885KMT2A 2858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.